Education
About Us
Working with TipRanks
Follow Us
AstraZeneca (AZN)
:AZN
AZN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$61.24 - $87.68
Previous CloseN/A
Volume1.80M
Average Volume (3M)6.05M
Market Cap
$214.69B
Enterprise Value$229.41B
Total Cash (Recent Filing)$7.37B
Total Debt (Recent Filing)$10.56B
Price to Earnings (P/E)30.7
Beta0.35
Next Earnings
Apr 29, 2025EPS Estimate
1.12Last Dividend Ex-Date
Feb 21, 2025Dividend Yield2.18%
Share Statistics
EPS (TTM)2.27
Shares Outstanding3,101,247,000
10 Day Avg. Volume4,909,177
30 Day Avg. Volume6,052,744
Financial Highlights & Ratios
PEG Ratio1.69
Price to Book (P/B)N/A
Price to Sales (P/S)4.31
Price to Cash Flow (P/CF)18.50
P/FCF Ratio25.00
Enterprise Value/Market Cap1.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.23
Enterprise Value/Ebitda13.32
Forecast
1Y Price Target
$88.78Price Target Upside27.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Clinical Trial SuccessDESTINY-Breast09 demonstrated a highly statistically significant and clinically meaningful improvement in PFS for Enhertu + pertuzumab vs the control arm standard of care in patients with 1L HER2+ metastatic breast cancer.
Product PipelineAZN has promising new products and pipeline, and participates in many large, high-growth markets.
Bears Say
Market ChallengesDecreasing roxadustat China sales are expected in subsequent years due to expected VBP inclusion.
Regulatory RisksCurrent investor concerns mainly revolve around risks to the China business due to alleged improper practices by former employees.
---
Ownership Overview
―
Insiders
5.78% Mutual Funds
0.09% Other Institutional Investors
93.22% Public Companies and
Individual Investors
AZN FAQ
What was AstraZeneca’s price range in the past 12 months?
AstraZeneca lowest stock price was $61.24 and its highest was $87.67 in the past 12 months.
What is AstraZeneca’s market cap?
AstraZeneca’s market cap is $214.69B.
When is AstraZeneca’s upcoming earnings report date?
AstraZeneca’s upcoming earnings report date is Apr 29, 2025 which is tomorrow.
How were AstraZeneca’s earnings last quarter?
AstraZeneca released its earnings results on Feb 06, 2025. The company reported $1.045 earnings per share for the quarter, beating the consensus estimate of $1.035 by $0.01.
Is AstraZeneca overvalued?
According to Wall Street analysts AstraZeneca’s price is currently Undervalued.
Does AstraZeneca pay dividends?
AstraZeneca pays a Semiannually dividend of $1.519 which represents an annual dividend yield of 2.18%. See more information on AstraZeneca dividends here
What is AstraZeneca’s EPS estimate?
AstraZeneca’s EPS estimate is 1.12.
How many shares outstanding does AstraZeneca have?
AstraZeneca has 3,101,247,000 shares outstanding.
What happened to AstraZeneca’s price movement after its last earnings report?
AstraZeneca reported an EPS of $1.045 in its last earnings report, beating expectations of $1.035. Following the earnings report the stock price went up 2.001%.
Which hedge fund is a major shareholder of AstraZeneca?
Currently, no hedge funds are holding shares in AZN
---
AstraZeneca Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$88.78 (27.61% Upside)
$88.78 (27.61% Upside)
Blogger Sentiment
Bullish
AZN Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.6%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.41%
12-Months-Change
Fundamentals
Return on Equity
17.60%
Trailing 12-Months
Asset Growth
2.88%
Trailing 12-Months
Company Description
AstraZeneca
AstraZeneca (AZN) is a global biopharmaceutical company engaged in the discovery, development, and commercialization of prescription medicines. Operating in over 100 countries, AstraZeneca focuses on three main therapeutic areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. The company is committed to delivering life-changing medicines and has a robust pipeline of innovative therapies.
---
AZN Company Deck
---
AZN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects strong overall performance with significant revenue growth, successful product approvals, and strategic pipeline advancements. However, challenges in the China market, anticipated headwinds from VBP and IRA, and increased operating expenses highlight areas of concern. The sentiment is balanced between strong growth prospects and operational challenges.Read More>---
AZN Stock 12 Month Forecast
Average Price Target
$88.78
▲(27.61% Upside)
Technical Analysis
Best Analysts Covering AZN
1 Year
1 Year Success Rate
18/25 ratings generated profit
1 Year Average Return
+10.16%
reiterated a buy rating 26 days ago
Copying Sachin Jain's trades and holding each position for 1 Year would result in 72.00% of your transactions generating a profit, with an average return of +10.16% per trade.
---